Evaluation of antiphospholipid antibodies in youths suffering from cerebral ischemia

International Journal of Neuroscience

Volumn 123, Issue 3, 2013, Pages 209-212

  Goldust, Mohamad ^a   Talebi, Mahnaz ^a   Majidi, Jafar ^a   Saatlou, Mohammad Amin Rezazadeh ^a   Rezaee, Elham ^b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anticardiolipin; Antiphospholipid antibodies (APA); Cerebral stroke

Indexed keywords

CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PHOSPHOLIPID ANTIBODY; WARFARIN;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; BRAIN ISCHEMIA; CLINICAL EVALUATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; TRANSIENT ISCHEMIC ATTACK;

EID: 84873914061     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2012.749256     Document Type: Article

References (25)

1. Ortiz GA, Lagari-Libhaber V, Prieto-Sanchez LM, Rabinstein AA. Propylthiouracil-induced lupus, antiphospholipid syndrome, and stroke in a patient with Graves hyperthyroidism. Arch Neurol. 2011;68(12):1587-90.
2. Wani AM, Hussain WM, Mejally MA, Ali KS, Raja SH, Maimani WA, et al. Catastrophic cerebral antiphospholipid syndrome presenting as cerebral infarction with haemorrhagic transformation after sudden withdrawal of warfarin in a patient with primary antiphospholipid syndrome. BMJ Case Rep. 2010;2010.
3. Svenungsson E, Gustafsson J, Leonard D, Sandling J, Gunnarsson I, Nordmark G, et al. A STAT4 risk allele is associated with ischaemic cerebrovascular events and antiphospholipid antibodies in systemic lupus erythematosus. Ann Rheum Dis. 2010;5(69):840-834.
4. Patrignani A, Nannicosta MP, Antonini L, D'Aroma A, De BG, Cicogna S. Infarto miocardico e cerebrale, come la presentazione iniziale della sindrome da anticorpi antifosfolipidi. G Ital Cardiol (Rome). 2009;10(4):259-62.
5. Heil JW, Malinowski L, Rinderknecht A, Broderick JP, Franz D. Use of intravenous tissue plasminogen activator in a 16-year-old patient with basilar occlusion. J Child Neurol. 2008;23(9):1049-53.
6. Cimaz R, Guerrini R. Epilepsy in lupus. Lupus. 2008; 17(9):777-79.
7. Legierse CM, Canninga-Van Dijk MR, Bruijnzeel-Koomen CA, Kuck-Koot VC. Sneddon syndrome and the diagnostic value of skin biopsies-three young patients with intracerebral lesions and livedo racemosa. Eur J Dermatol. 2008; 18(3):322-28.
8. Lonnebakken MT, Gerdts E. Libman-Sacks endocarditis and cerebral embolization in antiphospholipid syndrome. Eur J Echocardiogr. 2008;9(1):192-93.
9. Carhuapoma JR, D'Olhaberriague L, Levine SR. Moyamoya syndrome associated with Sneddon's syndrome and antiphospholipid-protein antibodies. J Stroke Cerebrovasc Dis. 1999;8(2):51-6.
10. Rahemtullah A, Van Cott EM. Hypercoagulation testing in ischemic stroke. Arch Pathol Lab Med. 2007;131(6):890-901.
11. Gupta PK, Ramnath KP, Sudhakar PJ. Bilateral medial cerebellar infarction in a patient positive for lupus anticoagulant. J Thromb Thrombolysis. 2007;23(3):241-4.
12. Hughes GR, Harris EN, Gharavi AE. The syndrome of thrombosis, abortion, and neurological disease. Contrib Nephrol. 1984;43:9-11.
13. Ciubotaru CR, Esfahani F, Benedict RH, Wild LM, Baer AN. Chorea and rapidly progressive subcortical dementia in antiphospholipid syndrome. J Clin Rheumatol. 2002;8(6):332-9.
14. Nencini P, Baruffi MC, Abbate R, Massai G, Amaducci L, Inzitari D. Lupus anticoagulant and anticardiolipin antibodies in young adults with cerebral ischemia. Stroke. 1992;23(2):189-93.
15. Hess DC, Taormina M, Thompson J, Sethi KD, Diamond B, Rao R, et al. Cognitive and neurologic deficits in the MRL/lpr mouse: a clinicopathologic study. J Rheumatol. 1993;20(4):610-7.
16. Muscal E, Brey RL. Antiphospholipid syndrome and the brain in pediatric and adult patients. Lupus. 2010;19(4):406-11.
17. Kalashnikova LA, Nasonov EL, Aleksandrova EN, Kosheleva NM, Reshetniak TM, Salozhin KV. Zh Nevrol Psikhiatr Im S S Korsakova. 1997;97(6):59-65.
18. Tietjen GE, Day M, Norris L, Aurora S, Halvorsen A, Schultz LR, et al. Role of anticardiolipin antibodies in young persons with migraine and transient focal neurologic events: a prospective study. Neurology. 1998;50(5):1433-40.
19. Kalashnikova LA, Efremov EE, Nasonov EL, Aleksandrova EN, Kosheleva NM, Reshetniak TM. Ter Arkh. 1998;70(5):48-51.
20. Verro P, Levine SR, Tietjen GE. Cerebrovascular ischemic events with high positive anticardiolipin antibodies. Stroke. 1998;29(11):2245-53.
21. Kushner M, Simonian N. Lupus anticoagulants, anticardiolipin antibodies, and cerebral ischemia. Stroke. 1989;20(2): 225-9.
22. Trimble M, Bell DA, BrienW, Hachinski V, O'Keefe B,McLay C, et al. The antiphospholipid syndrome: prevalence among patients with stroke and transient ischemic attacks. Am J Med. 1990;88(6):593-7.
23. Urbanus RT, Siegerink B, Roest M, Rosendaal FR, de Groot PG, Algra A. Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study. Lancet Neurol. 2009;8(11):998-1005.
24. van Goor MP, Alblas CL, Leebeek FW, Koudstaal PJ, Dippel DW.Do antiphospholipid antibodies increase the long-termrisk of thrombotic complications in young patients with a recent TIA or ischemic stroke? Acta Neurol Scand. 2004;109(6):410-5.
25. Levine SR, Brey RL. Neurological aspects of antiphospholipid antibody syndrome. Lupus. 1996;5(5):347-53.